Indofarma Tbk. vs Kokoh Exa Nusantara Tbk — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Kokoh Exa Nusantara Tbk trades at Rp134 (market cap 576.31B, 60.42M 24h volume). The key difference: Kokoh Exa Nusantara Tbk is the larger of the two by market cap. Which is the better fit depends on your goals.
| INAF | KOCI | |
|---|---|---|
Market Cap | 390.51B | 576.31B |
Volume | — | 60.42M |
Lot | — | 604.22K |
Turnover | — | 7.95B |
Average Price | — | 131.63 |
Value | — | 7.95B |
Indicative Equilibrium Price | — | 134 |
Indicative Equilibrium Volume | — | 5.59K |
Trailing returns across standard periods
Latest headlines on both assets
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →PT Kokoh Exa Nusantara Tbk (the Entity) was established based on Notarial Deed No. 173, dated July 31, 2019 of Dwi Rossulliati, S.H., notary in Mojokerto Regency. The Entity started its commercial operations in 2020. PT Exa Nusa Persada is its ultimate parent entity.
Read more on KOCI →